A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 1 PART1, 2006, Pages 103-109

  Terano, Akira ^a   Arakawa, Tetsuo ^b   Sugiyama, Toshiro ^c   Yoshikawa, Toshikazu ^d   Haruma, Ken ^e   Asaka, Masahiro ^c   Shimosegawa, Tooru ^f   Sakaki, Nobuhiro ^g   Ishii, Hiromasa ^h   Sakamoto, Choitsu ⁱ   Takahashi, Shin Ichi ^j   Kinoshita, Yoshikazu ^k   Fujioka, Toshio ^l   Kobayashi, Kenzo ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e KAWASAKI MEDICAL SCHOOL   (Japan)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^h KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ NIPPON MEDICAL SCHOOL   (Japan)

^j KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^l OITA UNIVERSITY   (Japan)

more..

Author keywords

Gastric ulcer; Helicobacter pylori; Pepsinogen; Rebamipide; Ulcer healing

Indexed keywords

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; LANSOPRAZOLE; REBAMIPIDE; UREASE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG SCREENING; ENDOSCOPY; EPIGASTRIC PAIN; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ILEUS; JAPAN; LARYNX DISORDER; MAJOR CLINICAL STUDY; MALAISE; MALE; MELENA; PHARYNX DISEASE; PRIORITY JOURNAL; STOMACH ULCER; ULCER HEALING; UREA BREATH TEST;

EID: 33645213007     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.04191.x     Document Type: Article

References (31)

1. Malfertheiner P Leodolter A Peitz U Cure of Helicobacter pylori-associated ulcer disease through eradication Baillieres Best PractResClinGastroenterol 2000 14 119 32
2. Sung JJ Chung SC Ling TK et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori NEnglJMed 1995 332 139 42
3. Hosking SW Ling TK Chung SC et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial Lancet 1994 343 508 10
4. Lam SK Ching CK Lai et al. Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study Gut 1997 41 43 8
5. Colin R Hepylog Investigator Study Group. Duodenal ulcer healing with 1-week eradication triple therapy followed, or not, by anti-secretory treatment: a multicentre double-blind placebo-controlled trial AlimentPharmacolTher 2002 16 1157 62
6. Treiber G Lambert JR The impact Helicobacter pylori eradication on peptic ulcer healing AmJGastroenterol 1998 93 1080 4
7. Witteman EM Mravunac M Becx MJ et al. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori JClinPathol 1995 48 250 6
8. Iijima K Ohara S Sekine T Kato K Asaki S Shimosegawa T Change in gastric acid secretion assayed by endoscopic test before and after Helicobacter pylori eradication Gut 2000 46 20 6
9. Arakawa T Kobayashi K Yoshikawa T Tarnawski A Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing DigDisSci 1998 43 9 Suppl. 5S 13S
10. Yamasaki K Kanbe T Chijiwa T Ishiyama H Morita S Gastric mucosal ptotection by OPC-12759, a novel antiulcer compound, in the rat EurJPharmacol 1987 142 23 9
11. Klein A Kluge S Peskar BM Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats DigDisSci 1993 38 1441 9
12. Tarnawski A Arakawa T Kobayashi K Rebamipide treatment activated epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats DigDisSci 1998 43 9 Suppl. 90S 98S
13. Yoshikawa T Naito Y Tanigawa T Kondo M Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance Arzneimittelforshung 1993 43 363 6
14. Yoshikawa T Naito Y Tanigawa T et al. Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study Free RadicBiolMed 1995 18 117 23
15. Ogino K Hobara T Ishiyama H et al. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethldithiocarbamate-induced antral gastric ulcer in rats EurJPharmacol 1992 212 9 13
16. Suzuki M Miura S Mori M et al. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants Gut 1994 35 1375 8
17. Haruma K Ito M Kido S et al. Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis DigDisSci 2002 47 862 7
18. Higuchi K Arakawa T Nebiki H et al. Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status DigDisSci 1998 43 9 Suppl. 99S 106S
19. Fujioka T Arakawa T Shimoyama T et al. Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multi-center trial AlimentPharmacolTher 2003 18 Suppl. 1 146 52
20. Lai KC Hui WM Wong BCY Hu WHC Lam SK Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage AlimentPharmacolTher 2000 14 1071 6
21. Unge P Kimura K Sipponen P et al. Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features? ScandJGastroenterol 2003 38 482 90
22. Kurata J Nogawa A Watanabe Y Lawai K Peptic ulcer disease mortality. Comparison of native Japanese, Japanese Americans, and Caucasian Americans JClinGastroenterol 1994 18 145 54
23. Furuta T El-Omar EM Xiao F et al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan Gastroenterology 2002 123 92 105
24. Tahir H Sumii K Haruma K et al. A statistical evaluation on the age and sex distribution of basal serum gastrin and gastric acid secretion in subjects with or without peptic ulcer disease Hiroshima JMedSci 1984 33 125 30
25. Higuchi K Fujiwara Y Tominaga K et al. Is eradication sufficient to heal gastric ulcers in patients with Helicobacter pylori? A randomized controlled prospective study AlimentPharmacolTher 2003 17 111 17
26. 13C-urea breath test for the diagnosis of Helicobacter pylori infection JGastroenterol 2003 38 937 41
27. Kato M Asaka M Sugiyama T et al. Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients DigDisSci 1998 43 9 Suppl. 198S 202S
28. Wagner S Haruma K Gladziwa U et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication AmJGastroenterol 1994 89 1211 18
29. Sipponen P Samloff IM Saukkonen M Varis K Serum pepsinogen I and II and gastric mucosal histology after partial gastrectomy Gut 1985 26 1179 82
30. Festen HP Tuynman HA Defize J et al. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels DigDisSci 1986 31 561 6
31. Brunner G Hell M Hengels KJ Hennig U Fuchs W Influence of lansoprazole on intragastric 24-hr pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers Digestion 1995 56 137 44